With an income increase of 65.85% in the second quarter 2026, year on year to cumulative value of $8,743 million, and with 13,000 employees, Amgen Inc 's income per employee grew on trailing twelve month basis to $ 672,538, this marks a new company high for all of 13,000 employees.
The Healthcare sector has seen employees of 9 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 287, from total ranking in previous quarter at 377.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AMGN Net Income per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Net Income Change	65.85 %	5.14 %	112.6 %	13.64 %	91.96 %
Net Income per Employee (TTM) $	672,538	600,000	593,154	538,846	509,154
AMGN's Total Ranking	# 287	# 377	# 303	# 288	# 301
Seq. Net Income Change	30.57 %	36.46 %	-58.55 %	124.58 %	-17.23 %

AMGN Company Profile >> Back to AMGN Efficiency Comparisons >> Compare AMGN Net Income per Employee to its Competitors

AMGN Net Income per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 10
Healthcare Sector	# 41
Overall Market	# 287

Net Income per Employee Statistics
High	Average	Low
$ 672,538	$ 414,821	$ 152,231
(Jun 30 2026)		(Dec 31 2017)

Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector	Income per Employee	Income 12 month ending Jun 30 2026	Number of Employees Jun 30 2026
Agenus Inc	1,135,037.04	$ 91.938 Million	81
Tg Therapeutics Inc	1,106,491.23	$ 441.490 Million	399
Halozyme Therapeutics Inc	977,768.32	$ 413.596 Million	423
Zevra Therapeutics Inc	949,245.90	$ 57.904 Million	61
United Therapeutics Corporation	936,357.14	$ 1,310.900 Million	1,400
Protagenic Therapeutics Inc new	910,314.00	$ 5.462 Million	6
Elite Pharmaceuticals Inc	871,814.86	$ 56.668 Million	65
Krystal Biotech Inc	818,525.42	$ 241.465 Million	295
The Greater Cannabis Company Inc	740,754.00	$ 0.741 Million	1
Omeros Corporation	713,291.43	$ 124.826 Million	175
Prestige Consumer Healthcare Inc	712,757.89	$ 406.272 Million	570
Amgen Inc	672,538.46	$ 8,743.000 Million	13,000
Atlantic Coastal Acquisition Corp Ii	670,333.33	$ 2.011 Million	3
Illumina Inc	644,531.25	$ 825.000 Million	1,280
Liquidia Corporation	641,694.44	$ 138.606 Million	216
Harmony Biosciences Holdings inc	618,668.94	$ 181.270 Million	293
Protagonist Therapeutics inc	616,272.73	$ 81.348 Million	132
Theravance Biopharma inc	597,866.67	$ 53.808 Million	90
Vaxart Inc	593,676.92	$ 38.589 Million	65
Glucotrack Inc	554,600.00	$ 8.319 Million	15
Eli Lilly And Company	534,224.00	$ 26,711.200 Million	50,000
Silexion Therapeutics Corp	489,714.29	$ 6.856 Million	14
Sanuwave Health Inc	488,872.73	$ 26.888 Million	55
Acadia Pharmaceuticals Inc	476,796.99	$ 380.484 Million	798
Biolife Solutions Inc	374,070.97	$ 57.981 Million	155
Indivior Pharmaceuticals Inc	356,000.00	$ 356.000 Million	1,000
Neurocrine Biosciences Inc	352,750.00	$ 705.500 Million	2,000

Date modified: 2026-09-13T23:23:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.